The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B (vol 71, pg 281, 2016)

被引：0
|
作者：
Solomon, M.
Schechter, M.
Liu, A. Y.
机构：
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2016年 / 72卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E82 / E82
页数：1
相关论文
共 50 条
  • [31] Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention
    Mugwanya, Kenneth K.
    Baeten, Jared M.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (02) : 265 - 273
  • [32] DISCOVER in Europe: a sub-analysis of the phase 3 randomized, controlled trial of daily emtricitabine/tenofovir alafenamide (F/TAF) or emtricitabine/tenofovir disoproxil fumarate (F/TDF) for HIV pre-exposure prophylaxis (PrEP)
    Post, F.
    Spinner, C.
    Coll, P.
    Hawkins, T.
    Anderson, J.
    Zhong, L.
    McCallister, S.
    HIV MEDICINE, 2019, 20 : 243 - 244
  • [33] Clinical trial simulation to evaluate tenofovir disoproxil fumarate/emtricitabine HIV pre-exposure prophylaxis dosing during pregnancy
    Scott, Rachel K.
    Yu, Yifan
    Marzinke, Mark A.
    Coleman, Jenell S.
    Hendrix, Craig W.
    Bies, Robert
    FRONTIERS IN REPRODUCTIVE HEALTH, 2023, 5
  • [34] Short Communication: Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis?
    Taramasso, Lucia
    Riccardi, Niccolo
    Del Puente, Filippo
    Bruzzone, Bianca
    Ripamonti, Diego
    D'Ambrosio, Beatrice
    Viscoli, Claudio
    Di Biagio, Antonio
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 (02) : 168 - 170
  • [35] Decreases in cholesterol in HIV-seronegative men using emtricitabine/tenofovir pre-exposure prophylaxis: lipid results of iPrEx
    Mulligan, K.
    Glidden, D. V.
    Anderson, P. L.
    McMahan, V.
    Guanira, J. V.
    Lama, J. R.
    Buchbinder, S. P.
    Chariyalertsak, S.
    Bekker, L-G
    Schechter, M.
    Veloso, V. G.
    Wang, F.
    Grant, R. M.
    ANTIVIRAL THERAPY, 2013, 18 : A6 - A7
  • [36] Emtricitabine/tenofovir alafenamide usage in a Scottish sexual health service providing HIV pre-exposure prophylaxis: A service evaluation
    Burley, Nathan
    MacDonald, Rona
    Khan, Aafreen
    INTERNATIONAL JOURNAL OF STD & AIDS, 2024, 35 (04) : 308 - 310
  • [37] Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial
    Mandala, Justin
    Nanda, Kavita
    Wang, Meng
    De Baetselier, Irith
    Deese, Jennifer
    Lombaard, Johan
    Owino, Fredrick
    Malahleha, Mookho
    Manongi, Rachel
    Taylor, Douglas
    Van Damme, Lut
    BMC PHARMACOLOGY & TOXICOLOGY, 2014, 15
  • [38] Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial
    Justin Mandala
    Kavita Nanda
    Meng Wang
    Irith De Baetselier
    Jennifer Deese
    Johan Lombaard
    Fredrick Owino
    Mookho Malahleha
    Rachel Manongi
    Douglas Taylor
    Lut Van Damme
    BMC Pharmacology and Toxicology, 15
  • [39] HIV pre-exposure prophylaxis as an entry point to the elimination of hepatitis B virus
    Khwairakpam, Giten
    Hicks, Jessica
    Penicaud, Capucine
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (11): : 967 - 967
  • [40] Infant Exposure to Tenofovir and Emtricitabine through Breast Milk when Used as Pre-exposure Prophylaxis by HIV-uninfected Lactating Women
    Mugwanya, Kenneth
    Hendrix, Craig
    Mugo, Nelly
    Marzinke, Mark
    Katabira, Elly
    Ngure, Kenneth
    Semiyaga, Nulu
    John-Stewart, Grace
    Muwonge, Timothy
    Muthuri, Gabriel
    Stergachis, Andy
    Celum, Connie
    Baeten, Jared
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 42 - 42
12345